ARTICLE
22 April 2019

A Game Changer For Financial Investors In The German Health Care Sector

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
On March 14, 2019, the German Bundestag passed the Schedule Service and Supply Act, generally aiming to improve service levels within the statutory health insurance system.
Germany Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

The Schedule Service and Supply Act aims to improve service levels within the statutory health insurance system.

On March 14, 2019, the German Bundestag passed the Schedule Service and Supply Act ("Terminservice- und Versorgungsgesetz, TSVG"), generally aiming to improve service levels within the statutory health insurance system. Together with those regulations, the TSVG contains a set of rules that are of high interest for private equity investors active in the German healthcare sector.

The now approved rules and regulations affect the investment into medical supply centers ("Medizinische Versorgungszentren, MVZ"), via hospitals and nonmedical dialysis suppliers which are the only inroads into the statutory health supply system available for—and, in fact, largely used by—sponsors (the others being nonprofit organizations and municipalities which by definition are no viable options for investors).

The new law states that the incorporation of an MVZ via a nonmedical dialysis supplier shall only be applicable to an MVZ providing subject-related medical care (i.e., medical care in connection with dialysis services or overall care for renal patients), thus making these investment vehicles unavailable for the establishment of MVZs in other disciplines, such as ophthalmology or radiology.

The incorporation of MVZs via hospitals has not been restricted for any disciplines in human medicine, but the establishment of dental MVZs will be affected by a newly designed quota system: Generally, one hospital (including all MVZs owned and operated by it) may not exceed a share of 10 percent in the supply of dental services in the respective planning area (Planungsbereich) of the Association of Statutory Health Insurance Dentists (Kassenzahnärztliche Vereinigung) where the MVZ is located. In planning areas with a deficiency of dental supply, the quota is 20 percent; in planning areas with a surplus of dental supply, the quota is 5 percent. The quota system will not be applied retroactively to MVZs which have been incorporated already, but it comes into effect in case of an expansion of such MVZs.

On April 12, 2019, the TSVG bill was approved by the Federal Council (Bundesrat) and is expected to enter into force in the course of April 2019.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

ARTICLE
22 April 2019

A Game Changer For Financial Investors In The German Health Care Sector

Germany Food, Drugs, Healthcare, Life Sciences

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More